Explore how IACS-10759 targets cancer's metabolic vulnerabilities through OXPHOS inhibition, offering new hope for treating aggressive cancers.
Explore the journey of IACS-010759, a mitochondrial complex I inhibitor that showed promise in targeting cancer metabolism but faced challenges in clinical trials.